| First Author | Wang Y | Year | 2020 |
| Journal | Diabetes | Volume | 69 |
| Issue | 8 | Pages | 1708-1722 |
| PubMed ID | 32404350 | Mgi Jnum | J:296911 |
| Mgi Id | MGI:6460229 | Doi | 10.2337/db19-0906 |
| Citation | Wang Y, et al. (2020) m(6)A mRNA Methylation Controls Functional Maturation in Neonatal Murine beta-Cells. Diabetes 69(8):1708-1722 |
| abstractText | The N (6)-methyladenosine (m(6)A) RNA modification is essential during embryonic development of various organs. However, its role in embryonic and early postnatal islet development remains unknown. Mice in which RNA methyltransferase-like 3/14 (Mettl3/14) were deleted in Ngn3(+) endocrine progenitors (Mettl3/14 (nKO) ) developed hyperglycemia and hypoinsulinemia at 2 weeks after birth. We found that Mettl3/14 specifically regulated both functional maturation and mass expansion of neonatal beta-cells before weaning. Transcriptome and m(6)A methylome analyses provided m(6)A-dependent mechanisms in regulating cell identity, insulin secretion, and proliferation in neonatal beta-cells. Importantly, we found that Mettl3/14 were dispensable for beta-cell differentiation but directly regulated essential transcription factor MafA expression at least partially via modulating its mRNA stability. Failure to maintain this modification impacted the ability to fulfill beta-cell functional maturity. In both diabetic db/db mice and patients with type 2 diabetes (T2D), decreased Mettl3/14 expression in beta-cells was observed, suggesting its possible role in T2D. Our study unraveled the essential role of Mettl3/14 in neonatal beta-cell development and functional maturation, both of which determined functional beta-cell mass and glycemic control in adulthood. |
